You are here: Industry Insights > COVID-19

News List

GSK buys stake in Vir Biotechnology in search of Covid-19 therapies pharmaceutical-technology
April 08, 2020
GlaxoSmithKline (GSK) has agreed to invest $250m in Vir Biotechnology for the research and development (R&D) of antibodies to treat Covid-19 infection.
Takeda teams up with plasma firms for Covid-19 hyperimmune therapy pharmaceutical-technology
April 08, 2020
Takeda Pharmaceutical and its partner CSL Behring have teamed up with plasma companies Biotest, BPL, LFB and Octapharma to develop a hyperimmune therapy for Covid-19.
Sharp Supports Development of COVID-19 Vaccines and Treatments contractpharma
April 08, 2020
Sharp Clinical, a provider of global clinical supply services, has confirmed that it is involved in supporting six clinical trials related to COVID-19.
BioIVT Opens New Blood Donor Center contractpharma
April 08, 2020
To support Boston-area research into COVID-19 therapies, vaccines and diagnostics.
FDA’s CTAP to Expedite COVID-19 Countermeasures contractpharma
April 08, 2020
New program across public, academic and private sectors aims to expedite the development of life-saving treatments.
Winnoz Technology in the Fight Against COVID-19 prnasia
April 07, 2020
COVID-19 is now characterized as a pandemic by WHO. A tremendous amount of fear and anxiety continues to impact large populations as a result of this unprecedented situation, in large part due to the confusion that results from the similarity in symptoms
Prosegur Security is Managing Critical Infrastructure during the COVID-19 outbreak using Willowmore's Smart Access Control System and Smart Locks prnasia
April 07, 2020
The global COVID-19 outbreak has affected many governments, businesses and individuals. With well-considered and measured approaches to contain the virus, Singapore businesses have been proactive in using Willowmore's technologies to minimise physical con
From China to the World, Fosun's Fight against COVID-19 Continues prnasia
April 07, 2020
At 7:00 pm Beijing time on April 6, Fosun hosted a global virtual conference on fighting against COVID-19 on the 39th floor of Fosun's headquarters - the Bund Finance Center in Shanghai.
NICE publishes four more rapid guidelines in response to pandemic pharmatimes
April 07, 2020
The National Institute for Health and Care Excellence (NICE) has published four new rapid guidelines on the active management of patients with suspected and confirmed COVID-19, and in patients without COVID-19.
Trial drug can significantly block early stages of COVID-19 in engineered human tissues worldpharmanews
April 07, 2020
An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page